Professional Education

Find your care

Our specialists provide a wide range of treatments, including clinical trial therapies. Call 310-825-9011 to learn more about adult congenital heart disease treatment.

This is for our professional colleagues who care for adults with Congenital Heart Disease, for professional colleagues with an interest in ACHD, and for trainees seeking to improve their knowledge of ACHD.

The Ahmanson/UCLA Adult Congenital Heart Disease Center presents:

New Frontiers for the Fontan Survivor

Challenges, Opportunities and the Ultimate Destination of Heart/Liver Transplantation

Saturday, September 21, 2019

UCLA Meyer & Renee Luskin Conference Center, 425 Westwood Plaza, Los Angeles, CA

This one-day symposium provides a comprehensive update on the long-term issues faced by adult Fontan survivors. The course focuses on patients with “failing” Fontan physiology and the available tools and therapies for the treatment of this challenging subset of patients, including updates on medical therapies, catheter-based and surgical techniques for palliation and support. The ultimate therapeutic options of orthotopic heart and multi-organ transplantation are covered in detail as the need grows in this aging Fontan population. The target audience includes adult and pediatric congenital cardiologists, congenital and transplant cardiac surgeons, heart failure/transplant specialists, hepatologists, liver transplant surgeons, cardiac intensivists, cardiology and cardiac surgery trainees, cardiac nurses, nurse practitioners and physician assistants.

  1. Growing Up With a Fontan – Leigh Reardon, MD:
  2. Medical Therapies – Gentian Lluri, MD, PhD:
  3. The role of Echocardiographic Imaging and Exercise Testing – Jeannette Lin, MD:
  4. The Role of Cardiac Catheterization – Jamil Aboulhosn, MD -
  5. The Role of MRI and CT Imaging –  Ashley Prosper, MD:
  6. Fontan Associated Liver Disease - Robert S. Venick, MD:
  7. UCLA Fontan Survivorship Protocol for the Stable Outpatient - Adam Small, MD:
  8. Care for the "Stable" Fontan Survivor: Q&A:
  9. How Do We Define a "Failing" Fontan? - Paul Clift, MD:
  10. Electrical Interventions for the Failing Fontan - Jeremy Moore, MD:
  11. Catheter Based Interventions for Failing Fontan - Daniel Levi, MD:
  12. Fontan Conversion Surgery - Hillel Laks, MD:
  13. "Unstable" Fontan Survivor - Weiyi Tan, MD:
  14. Care for "Unstable" Fontan Survivor: Q&A
  15. OHT/OLT/MCS Evaluation Process – Arnold S. Baas, MD:
  16. Update on UNOS Organ Allocation – Eugene DePasquale, MD:
  17. Multi-Disciplinary Operative Planning - Jeannette Lin, MD:
  18. Management & Optimization of Patient Awaiting Transplant - D. Cruz, MD, PhD: :
  19. Mechanical Support Considerations - Leigh Reardon, MD:
  20. UCLA Fontan Protocol for Patients Awaiting Transplant – Gentian Lluri, MD, PHD:
  21. Evaluation for Transplant and Mechanical Support - Q&A:
  22. Challenges & Considerations of OHT in the Failing Fontan - Reshma Biniwale, MD:
  23. Tribute to Kelly Tarantello :
  24. Challenges and Considerations of Combined OHT/OLT – Fady Kaldas, MD:
  25. Intraoperative Management of OHT/OLT - Christopher L. Wray, MD:
  26. Peri and Post Operative ICU Care - Ben Kratzert, MD:
  27. Patient Story – Tom Townsend:
  28. The Fontan Operation: What We Have Learned and Where We Are Going – Glen Van Arsdell, MD:

Adult Congenital Heart Disease: Quality Care in the Era of Certification and Accreditation - A Practical Approach

February 10-11, 2017
UCLA Meyer and Renee Luskin Conference Center & Ronald Reagan UCLA Medical Center, Los Angeles, CA

There are now an estimated 1.5 million adults living with congenital heart disease in the United States. In order to meet the growing demand for adult congenital heart disease (ACHD) specialty care, a multi-disciplinary and comprehensive approach to program development and patient care is needed. This course highlights the components of a multidisciplinary ACHD comprehensive care center, and provides an overview of complex clinical scenarios which outlines how specialty ACHD care is provided in the U.S. based on practice guidelines and accreditation standards.

This conference seeks to teach attendees about subspecialty practice standards for ACHD care to meet the life-long needs of this rapidly growing patient population. Over the past decade, the U.S. has witnessed expanding numbers of cardiology “ACHD” providers stepping up in an effort to shore up the deficits in ACHD specialty care. However, these providers vary widely with a broad spectrum of educational preparation and institutional preparation, which ultimately may impact the quality of care for ACHD patients.

The following topics can be found in the videos above:

Saturday, February 11, 2017

  • Moderator: Jamil Aboulhosn, MD
  • From Genomics to 3-D Printing in CHD: The Future is Here by Dr. Jamil Aboulhosn
  • Illustrative Case Presentations - Presenters: Dr. Joanna Ghobrial, Dr. Anne Kemble, Dr. Ian Lindsay, and Dr. Sanjay Sinha
  • Illustrative Case Presentations #2 - Presenter: Dr. Ian Lindsay
  • Panel: Dr. John S. Child, Dr. Hillel Laks, Dr. Jeannette Lin, Dr. Greg Perens, Dr. Leigh Christopher Reardon, and Dr. Kevin M. Shannon
  • Hands-On Session (Groups with 20 minute rotation)
  • MRI/CTA Case Reviews by Dr. J. Paul Finn and Dr. Perangelo Renella
  • Echocardiography Case Reviews by Dr. John S. Child, Dr. Jeannette Lin, and Dr. Gentian Lluri
  • Gross Pathology Station by Dr. Michael C. Fishbein and Dr. Gregory A. Fishbein
  • VAD/Surgical and Interventional Work Station by Dr. Reshma Biniwale, Dr. Daniel S. Levi, Dr. Leigh Christopher Reardon, and Dr. Morris M. Salem
  • Pacemaker/ICD Stimulations in ACHD by Dr. Jeremy Moore and Dr. Kevin Shannon
  • Closing Comments - Dr. Jamil Aboulhosn
  • "Developing a Better Understanding of Congenital Cardiac Anatomy an Physiology through Art" - Collaboration between The Getty Museum and Ahmanson/UCLA Adult Congenital Heart Disease Center
  • Adjourn